CWM
CRL icon

Calamos Wealth Management’s Charles River Laboratories CRL Stock Holding History

Calamos Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,830
Closed -$562K – 236
2014
Q4 		$562K Sell
8,830
-1,030
-10% -$64.6K 0.16% 165
2014
Q3 		$589K Sell
9,860
-10
-0.1% -$572 0.17% 171
2014
Q2 		$528K Buy
+9,870
New +$542K 0.15% 179

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Calamos Wealth Management's CRL Position: Q1 2015 in Review

Calamos Wealth Management sold out of Charles River Laboratories (CRL) in Q1 2015, closing a stake of 8,830 shares — an estimated $562K sold.

Calamos Wealth Management first reported a position in CRL in Q2 2014 and held it in 3 quarters. The position peaked at $589K in Q3 2014. 259 funds tracked by Wall St. Rank hold CRL as of Q1 2015.

  • Calamos Wealth Management reported no remaining Charles River Laboratories position as of Q1 2015 after selling out during the quarter.
  • Calamos Wealth Management sold 8,830 Charles River Laboratories shares in Q1 2015, an estimated $562K.
  • Calamos Wealth Management first reported a position in Charles River Laboratories in Q2 2014 and held it in 3 quarters.
  • Calamos Wealth Management's Charles River Laboratories position peaked at $589K in Q3 2014.
  • 259 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2015.

Based on Calamos Wealth Management's 13F filing for Q1 2015, filed 12 May 2015.